Catalio Capital Management
@cataliocapital.com
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Catalio Capital Management's Company Logos
Catalio Capital Management's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#091B59
Downriver
9, 27, 89
227, 82, 19
90, 70, 0, 65
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Catalio Capital Management
Catalio Capital Management is a renowned brand founded by George Petrocheilos and Dr. Jacob Vogelstein. They specialize in investing in breakthrough biomedical technology companies, both those created or referred by Catalio Capital Management and other innovative healthcare companies globally.
Offering a multi-strategy investment approach, Catalio Capital management has four primary strategies. First is their flagship private equity strategy, which invests in privately held biomedical technology companies at all stages, from seed to crossover. They also have a structured opportunities strategy that provides senior-secured financing to breakthrough biomedical technology companies.
Additionally, Catalio Capital Management has a public equities strategy that focuses on investing in global healthcare equities across sectors such as innovative drugs, devices, diagnostics, and data. Lastly, their co-investment vehicles offer direct access to their best deals to Catalio Limited Partners. Overall, Catalio Capital Management aims to produce exceptional returns by combining the best science, technology, management, and execution in their portfolio companies
